A novel, sensitive, simple, and accurate spectrophotometric technique for the determination of Loratadine (LD) drug in pure and pharmaceutical formulations was developed. It was created by the reaction of (LD) and a new organic reagent (A1) prepared from (TCH) and (A) in a base medium. TCH was prepared by heating at reflux of a mixture of carbon disulfide and aqueous hydrazine, while (A) was prepared by thermal melting of a mixture of TCH and nicotinic acid. The absorption of the product of LD and A1 was measured at 466 nm. Linearity ranged between (0.625-30μg.mL-1), molar absorptivity was (17918.92 L / mol.cm), limits of detection and quantification were (0.0705, 0.213 μg.ml-1), respectively. The method was applied successfully for the determination of LD in pure and pharmaceutical formulations.
Ahmed Mohammed, A., abdullah, S., & Abdulwahhab, G. (2022). Spectrophotometric Determination of Loratadine drug by New 6-hydrazineyl-3-(pyridiin-4-yl)-[1,2,4] triazolo[3, 4-b][1, 3 ,4]thiadiiazole A1 derived from isonicotinic acid in pure and pharmaceuticals formulation. Egyptian Journal of Chemistry, 65(132), 273-280. doi: 10.21608/ejchem.2022.122082.5467
MLA
Asmaa Ahmed Mohammed; shaimaa hatem abdullah; Ghazwan Hasan Abdulwahhab. "Spectrophotometric Determination of Loratadine drug by New 6-hydrazineyl-3-(pyridiin-4-yl)-[1,2,4] triazolo[3, 4-b][1, 3 ,4]thiadiiazole A1 derived from isonicotinic acid in pure and pharmaceuticals formulation", Egyptian Journal of Chemistry, 65, 132, 2022, 273-280. doi: 10.21608/ejchem.2022.122082.5467
HARVARD
Ahmed Mohammed, A., abdullah, S., Abdulwahhab, G. (2022). 'Spectrophotometric Determination of Loratadine drug by New 6-hydrazineyl-3-(pyridiin-4-yl)-[1,2,4] triazolo[3, 4-b][1, 3 ,4]thiadiiazole A1 derived from isonicotinic acid in pure and pharmaceuticals formulation', Egyptian Journal of Chemistry, 65(132), pp. 273-280. doi: 10.21608/ejchem.2022.122082.5467
VANCOUVER
Ahmed Mohammed, A., abdullah, S., Abdulwahhab, G. Spectrophotometric Determination of Loratadine drug by New 6-hydrazineyl-3-(pyridiin-4-yl)-[1,2,4] triazolo[3, 4-b][1, 3 ,4]thiadiiazole A1 derived from isonicotinic acid in pure and pharmaceuticals formulation. Egyptian Journal of Chemistry, 2022; 65(132): 273-280. doi: 10.21608/ejchem.2022.122082.5467